BNP Paribas Exane Has Lowered Expectations for BWX Technologies (NYSE:BWXT) Stock Price

Key Points

• BNP Paribas Exane cut BWX Technologies’ price target from $190 to $165 and maintained a “neutral” rating, implying about 17.4% upside from the stock’s current price.
• Analyst sentiment remains mixed but leans positive: BWXT has an overall “Moderate Buy” rating and an average price target of $213.75, despite several recent downgrades.
• BWXT shares fell 0.9% to $140.57, near their 52-week low, while the company reported quarterly EPS of $1.07 and 18% year-over-year revenue growth.

BWX Technologies (NYSE:BWXT - Get Free Report) had its price target lowered by research analysts at BNP Paribas Exane from $190.00 to $165.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently has a "neutral" rating on the technology company's stock. BNP Paribas Exane's price objective indicates a potential upside of 17.38% from the stock's current price.

Other equities research analysts have also issued reports about the stock. BTIG Research reissued a "buy" rating and issued a $235.00 target price on shares of BWX Technologies in a report on Tuesday, August 4th. Truist Financial decreased their price objective on shares of BWX Technologies from $212.00 to $202.00 and set a "hold" rating on the stock in a research report on Friday, August 14th. Wall Street Zen cut shares of BWX Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Weiss Ratings downgraded shares of BWX Technologies from a "buy (b-)" rating to a "hold (c+)" rating in a report on Wednesday, August 26th. Finally, Jefferies Financial Group started coverage on BWX Technologies in a research note on Thursday, September 3rd. They issued a "buy" rating and a $181.00 price target for the company. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $213.75.

BWX Technologies Stock Down 0.9%

Shares of BWXT stock traded down $1.24 during mid-day trading on Thursday, hitting $140.57. The company's stock had a trading volume of 474,167 shares, compared to its average volume of 1,024,469. The stock has a market cap of $12.88 billion, a price-to-earnings ratio of 36.36, a PEG ratio of 2.26 and a beta of 0.75. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.33 and a current ratio of 2.40. BWX Technologies has a 52-week low of $139.06 and a 52-week high of $241.82. The business has a 50-day moving average price of $161.30 and a 200 day moving average price of $189.19.

BWX Technologies (NYSE:BWXT - Get Free Report) last posted its earnings results on Monday, August 3rd. The technology company reported $1.07 EPS for the quarter, topping analysts' consensus estimates of $1.04 by $0.03. BWX Technologies had a net margin of 10.11% and a return on equity of 30.83%. The business had revenue of $901.62 million during the quarter, compared to the consensus estimate of $902.41 million. During the same quarter in the previous year, the firm posted $1.02 EPS. The firm's revenue was up 18.0% on a year-over-year basis. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. Research analysts predict that BWX Technologies will post 4.75 EPS for the current fiscal year.

Insider Activity

In other news, CEO Rex D. Geveden sold 10,000 shares of the stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $172.50, for a total transaction of $1,725,000.00. Following the completion of the transaction, the chief executive officer directly owned 192,491 shares in the company, valued at approximately $33,204,697.50. This represents a 4.94% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

Institutional Trading of BWX Technologies

Several hedge funds have recently made changes to their positions in the business. Cannell & Spears LLC lifted its stake in shares of BWX Technologies by 4.0% in the 1st quarter. Cannell & Spears LLC now owns 1,312 shares of the technology company's stock valued at $251,000 after purchasing an additional 50 shares in the last quarter. Private Advisor Group LLC lifted its position in BWX Technologies by 2.4% during the first quarter. Private Advisor Group LLC now owns 2,847 shares of the technology company's stock valued at $582,000 after buying an additional 67 shares in the last quarter. Moors & Cabot Inc. grew its stake in BWX Technologies by 3.7% during the fourth quarter. Moors & Cabot Inc. now owns 2,040 shares of the technology company's stock worth $353,000 after buying an additional 72 shares during the period. Beck Capital Management LLC increased its position in shares of BWX Technologies by 0.3% in the fourth quarter. Beck Capital Management LLC now owns 25,032 shares of the technology company's stock worth $4,327,000 after acquiring an additional 72 shares in the last quarter. Finally, Modera Wealth Management LLC raised its stake in shares of BWX Technologies by 4.6% in the 1st quarter. Modera Wealth Management LLC now owns 1,757 shares of the technology company's stock valued at $359,000 after acquiring an additional 77 shares during the period. 94.39% of the stock is currently owned by hedge funds and other institutional investors.

BWX Technologies Company Profile

BWX Technologies, Inc NYSE: BWXT is a technology and manufacturing company that specializes in nuclear components, systems and services. The company primarily serves government and commercial customers in the nuclear energy, national security and medical markets.

BWXT is a major supplier to the U.S. government and supports the U.S. Navy's nuclear propulsion program by designing and manufacturing nuclear reactors and related components for naval vessels. Its offerings also include nuclear fuel, reactor components, engineering and maintenance services, and technologies intended for advanced and small modular reactors.

Through its commercial and medical businesses, BWXT provides nuclear equipment and services for civilian power generation, produces medical radioisotopes and related technologies, and supports research and other specialized applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.